Your Source for Venture Capital and Private Equity Financings

Curie Therapeutics Raises $75M Series A

CAMBRIDGE, MA, Curie Therapeutics, a biotechnology company, announced a Series A investment of $75 million.
Curie Therapeutics, a biotechnology company incubated by Atlas Ventures, Access Biotechnology and RA Capital Management, announced a Series A investment of $75 million by its founding syndicate.

Curie Therapeutics is a fully integrated, next-generation radiopharmaceuticals company focused on pioneering a new class of targeted radiopharmaceuticals that are both safe and effective.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors

Featured Reading